Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Jul 3;20(8):892–893. doi: 10.1016/S1473-3099(20)30561-2

Exaggerated risk of transmission of COVID-19 by fomites

Emanuel Goldman a
PMCID: PMC7333993  PMID: 32628907

A clinically significant risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission by fomites (inanimate surfaces or objects) has been assumed on the basis of studies that have little resemblance to real-life scenarios.

The longest survival (6 days) of severe acute respiratory syndrome coronavirus (SARS-CoV) on surfaces was done by placing a very large initial virus titre sample (107 infectious virus particles) on the surface being tested.1 Another study that claimed survival of 4 days used a similarly large sample (106 infectious virus particles) on the surface.2 A report by van Doremalen and colleagues found survival of both SARS-CoV and SARS-CoV-2 of up to 2 days (on surfaces) and 3 days (in aerosols generated in the laboratory), but again with a large inoculum (105–107 infectious virus particles per mL in aerosols, 104 infectious virus particles on surfaces).3 Yet another study found long survival (5 days) of human coronavirus 229E on surfaces with what I would still consider a substantially large viral load (103 plaque-forming units) in a cell lysate.4 However, using a cell lysate rather than purified or semipurified virus might enable initial viral proliferation or protection from the effects of the sample drying out.

None of these studies present scenarios akin to real-life situations. Although I did not find measurements of coronavirus quantities in aerosol droplets from patients, the amount of influenza virus RNA in aerosols has been measured, with a concentration equivalent to 10–100 viral particles in a droplet, with even fewer infectious influenza virus particles capable of growth in a plaque assay.5 By contrast, one study found human coronavirus 229E to survive for only 3–6 h (depending on the surface tested), and human coronavirus OC43 to survive for 1 h, after drying on various surfaces including aluminum, sterile latex surgical gloves, and sterile sponges.6 In a study in which the authors tried to mimic actual conditions in which a surface might be contaminated by a patient, no viable SARS-CoV was detected on surfaces.7

A 2020 literature review8 included most of the studies I have cited here (and others), but adds no new research, and in my view, does not critically evaluate previously published studies. I am not disputing the findings of these studies, only the applicability to real life. For example, in the studies that used a sample of 107, 106, and 104 particles of infectious virus on a small surface area,1, 2, 3 these concentrations are a lot higher than those in droplets in real-life situations, with the amount of virus actually deposited on surfaces likely to be several orders of magnitude smaller.5 Hence, a real-life situation is better represented in the work of Dowell and colleagues7 in which no viable virus was found on fomites.

In my opinion, the chance of transmission through inanimate surfaces is very small, and only in instances where an infected person coughs or sneezes on the surface, and someone else touches that surface soon after the cough or sneeze (within 1–2 h). I do not disagree with erring on the side of caution, but this can go to extremes not justified by the data. Although periodically disinfecting surfaces and use of gloves are reasonable precautions especially in hospitals, I believe that fomites that have not been in contact with an infected carrier for many hours do not pose a measurable risk of transmission in non-hospital settings. A more balanced perspective is needed to curb excesses that become counterproductive.

This online publication has been corrected. The corrected version first appeared at thelancet.com/infection on July 30, 2020

Acknowledgments

I declare no competing interests.

References

  • 1.Rabenau HF, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr HW. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005;194:1–6. doi: 10.1007/s00430-004-0219-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Duan SM, Zhao XS, Wen RF, Huang JJ, Pi GH, Zhang SX. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003;16:246–255. [PubMed] [Google Scholar]
  • 3.van Doremalen N, Bushmaker T, Morris DH. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–1567. doi: 10.1056/NEJMc2004973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Warnes SL, Little ZR, Keevil CW. Human coronavirus 229E remains infectious on common touch surface materials. mBio. 2015;6:e01697–e01715. doi: 10.1128/mBio.01697-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lindsley WG, Blachere FM, Thewlis RE. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One. 2010;5 doi: 10.1371/journal.pone.0015100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sizun J, Yu MW, Talbot PJ. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections. J Hosp Infect. 2000;46:55–60. doi: 10.1053/jhin.2000.0795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dowell SF, Simmerman JM, Erdman DD. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis. 2004;39:652–657. doi: 10.1086/422652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104:246–251. doi: 10.1016/j.jhin.2020.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Lancet. Infectious Diseases are provided here courtesy of Elsevier

RESOURCES